OptiSkin Medical

New York, New York 10128

1 studies enrolling now · 12 studies all time

What they study most

Active Nonsegmental Vitiligo, Atopic Dermatitis, Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Eczema, Hidradenitis Suppurativa (HS), Plaque Psoriasis, Psoriasis, Psoriatic Arthritis, Psoriatic Nail, Stable Nonsegmental Vitiligo

Studies at this site

• A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) — Recruiting now
• A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
• Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense — Running, not enrolling
• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) — Completed
• A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 — Running, not enrolling
• A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria — Completed
• A Study of Barzolvolimab in Patients With Atopic Dermatitis — Running, not enrolling
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) — Running, not enrolling
• A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab — Completed
• A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis — Running, not enrolling
• Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. — Status unconfirmed
• Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging — Status unconfirmed